KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Short-term Investments (2017 - 2025)

Novartis Ag (NVS) has disclosed Short-term Investments for 9 consecutive years, with $98.0 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 95.1% to $98.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.0 million through Dec 2025, down 95.1% year-over-year, with the annual reading at $98.0 million for FY2025, 95.1% down from the prior year.
  • Short-term Investments hit $98.0 million in Q4 2025 for Novartis Ag, down from $2.0 billion in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $15.9 billion in Q4 2021 to a low of $98.0 million in Q4 2025.
  • Historically, Short-term Investments has averaged $6.1 billion across 5 years, with a median of $2.0 billion in 2024.
  • Biggest five-year swings in Short-term Investments: skyrocketed 735.8% in 2021 and later crashed 95.1% in 2025.
  • Year by year, Short-term Investments stood at $15.9 billion in 2021, then fell by 28.32% to $11.4 billion in 2022, then plummeted by 90.93% to $1.0 billion in 2023, then skyrocketed by 93.04% to $2.0 billion in 2024, then plummeted by 95.1% to $98.0 million in 2025.
  • Business Quant data shows Short-term Investments for NVS at $98.0 million in Q4 2025, $2.0 billion in Q4 2024, and $1.0 billion in Q4 2023.